Lumos Diagnostics products

FebriDx is a rapid, all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. FebriDx® can be used to help triage patients at the point of care to reduce uncertainty and avoid unnecessary antibiotics. Results within 10 minutes increases confidence in whether or not to prescribe an antibiotic. All-in-one test device allows doctors or nurses to test during triage. Instrument-free means no expensive equipment and a fully portable solution. Highly sensitive/specific dual biomarker technology provides reliable differentiation of viral and bacterial infections.

CoviDx™ SARS-CoV-2 Rapid Antigen Test is a lateral flow assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swabs and nasopharyngeal swabs from patients suspected of a Coronavirus-19 (COVID-19) infection by their healthcare provider within the first 5 days of symptoms.